Clinical trial
Safety Study of an Adjuvanted Candidate Influenza Vaccine to Prevent Influenza…
NCT00318058 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00318058 |
|---|---|
| Title | Safety Study of an Adjuvanted Candidate Influenza Vaccine to Prevent Influenza Disease in the Elderly Population |
| Official title | A Phase I/II, Open, Controlled Study in Order to Evaluate the Reactogenicity and the Immunogenicity of GlaxoSmithKline Biologicals Influenza Candidate Adjuvanted Vaccine in an Elderly Population Aged Over 65 Years Previously Vaccinated in 2004 With the Same Candidate Vaccine |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Biological |
| Interventions | influenza vaccine Fluarix, Adjuvanted Fluarix |
| Enrollment | 84 |
| Start date | Oct 3, 2005 |
| Primary completion | Nov 1, 2005 |
| Completion | Nov 4, 2005 |
| First posted | Apr 26, 2006 |
| Last update posted | May 8, 2017 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: